406
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Use of the Direct Compression Aid Ludiflash® for the preparation of pellets via wet extrusion/spheronization

, , , , &
Pages 1231-1243 | Received 05 Oct 2010, Accepted 22 Feb 2011, Published online: 25 Mar 2011

References

  • Mehta KA, Rekhi GS, Parikh DM. (2005). Extrusion/spheronization as a granulation technique. In: Parikh DM, ed. Handbook of Pharmaceutical Granulation Technology. Boca Raton: Taylor & Francis Group, pp. 333–363.
  • Ghebre-Sellassie I. (1989). Pellets: A general overview. In: Ghebre-Sellassie I, ed. Pharmaceutical Pelletization Technology. New York: Marcel Dekker, Inc., pp. 1–13.
  • Fielden KE, Newton JM. (1992). Extrusion and extruders. In: Swarbrick J, ed. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker, pp. 395–442.
  • Alvarez L, Concheiro A, Gómez-Amoza JL, Souto C, Martínez-Pacheco R. (2003). Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug. Eur J Pharm Biopharm, 55:291–295.
  • Charoenthai N, Kleinebudde P, Puttipipatkhachorn S. (2007a). Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose. AAPS Pharmscitech, 8:E64.
  • Charoenthai N, Kleinebudde P, Puttipipatkhachorn S. (2007b). Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization. J Pharm Sci, 96:2469–2484.
  • Dukic-Ott A, Remon JP, Foreman P, Vervaet C. (2007). Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation. Eur J Pharm Biopharm, 67:715–724.
  • Sriamornsak P, Nunthanid J, Luangtana-anan M, Weerapol Y, Puttipipatkhachorn S. (2008). Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts. Eur J Pharm Biopharm, 69:274–284.
  • Thommes M, Kleinebudde P. (2006a). Use of [kappa]-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur J Pharm Biopharm, 63:59–67.
  • Thommes M, Kleinebudde P. (2006b). Use of [kappa]-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Eur J Pharm Biopharm, 63:68–75.
  • Thommes M, Kleinebudde P. (2007b). Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters. AAPS Pharmscitech, 8:E95.
  • Kranz H, Jürgens K, Pinier M, Siepmann J. (2009). Drug release from MCC- and carrageenan-based pellets: experiment and theory. Eur J Pharm Biopharm, 73:302–309.
  • Tho I, Sande SA, Kleinebudde P. (2002). Pectinic acid, a novel excipient for production of pellets by extrusion/spheronisation: preliminary studies. Eur J Pharm Biopharm, 54:95–99.
  • Tho I, Sande SA, Kleinebudde P. (2003). Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronisation. Eur J Pharm Biopharm, 56:371–380.
  • Thommes M, Blaschek W, Kleinebudde P. (2007a). Effect of drying on extruded pellets based on [kappa]-carrageenan. Eur J Pharm Sci, 31:112–118.
  • Lustig-Gustafsson C, Kaur Johal H, Podczeck F, Newton JM. (1999). The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronisation. Eur J Pharm Sci, 8:147–152.
  • Sousa JJ, Sousa A, Podczeck F, Newton JM. (2002). Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int J Pharm, 232:91–106.
  • Ravisankar S, Vasudevan M, Gandhimathi M, Suresh B. (1998). Reversed-phase HPLC method for the estimation of acetaminophen, ibuprofen and chlorzoxazone in formulations. Talanta, 46:1577–1581.
  • Shipway PH, Hutchings IM. (1993). Fracture of brittle spheres under compression and impact loading. I. Elastic stress distributions. Philos MagA, 67:1389–1404.
  • Millili GP, Schwartz JB. (1990). The strength of microcrystallince cellulose pellets: The effect of granulating with water/ethanol mixtures. Drug Dev Ind Pharm, 16:1411–1426.
  • Tunón A, Gråsjö J, Alderborn G. (2003). Effect of intragranular porosity on compression behaviour of and drug release from reservoir pellets. Eur J Pharm Sci, 19:333–344.
  • Dreu R, Sirca J, Pintye-Hodi K, Burjan T, Planinsek O, Srcic S. (2005). Physicochemical properties of granulating liquids and their influence on microcrystalline cellulose pellets obtained by extrusion-spheronisation technology. Int J Pharm, 291:99–111.
  • Souto C, Rodríguez A, Parajes S, Martínez-Pacheco R. (2005). A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur J Pharm Biopharm, 61:94–99.
  • Tomer G, Newton JM. (1999). Water movement evaluation during extrusion of wet powder masses by collecting extrudate fractions. Int J Pharm, 182:71–77.
  • Lekhal A, Glasser BJ, Khinast JG. (2001). Impact of drying on the catalyst profile in supported impregnated catalysts. Chem Eng Sci, 56:4473–4487.
  • Kleinebudde P, Schröder M, Schultz P, Müller BW, Waaler T, Nymo L. (1999). Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures. Pharm Dev Technol, 4:397–404.
  • Schröder M, Kleinebudde P. (1995). Structure of disintegrating pellets with regard to fractal geometry. Pharm Res, 12:1694–1700.
  • Rough SL, Wilson DI. (2005). Extrudate fracture and spheronisation of microcrystalline cellulose pastes. J Mater Sci, 40:4199–4219.
  • Chopra R, Podczeck F, Newton JM, Alderborn G. (2002). The influence of pellet shape and film coating on the filling of pellets into hard shell capsules. Eur J Pharm Biopharm, 53:327–333.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.